These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28333923)

  • 1. Interdisciplinary approach at the primary healthcare level for Bolivian immigrants with Chagas disease in the city of São Paulo.
    Shikanai Yasuda MA; Sátolo CG; Carvalho NB; Atala MM; Ferrufino RQ; Leite RM; Furucho CR; Luna E; Silva RA; Hage M; de Oliveira CMR; Busser FD; de Freitas VLT; Wanderley DM; Martinelli L; Almeida SR; Viñas PA; Carneiro N
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005466. PubMed ID: 28333923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Trypanosoma cruzi infection among Bolivian immigrants in the city of São Paulo, Brazil.
    Luna EJ; Furucho CR; Silva RA; Wanderley DM; Carvalho NB; Satolo CG; Leite RM; Silveira C; Silva LM; Aith FM; Carneiro N; Shikanai-Yasuda MA
    Mem Inst Oswaldo Cruz; 2017 Jan; 112(1):70-74. PubMed ID: 27849221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chagas disease knocks on our door: a cross-sectional study among Latin American immigrants in Milan, Italy.
    Antinori S; Galimberti L; Grande R; Bianco R; Oreni L; Traversi L; Ricaboni D; Bestetti G; Lai A; Mileto D; Gismondo MR; Petullà M; Garelli S; De Maio G; Cogliati C; Torzillo D; Villa AM; Egidi AM; Repetto EC; Ridolfo AL; Corbellino M; Galli M
    Clin Microbiol Infect; 2018 Dec; 24(12):1340.e1-1340.e6. PubMed ID: 29555394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.
    Machado-de-Assis GF; Silva AR; Do Bem VA; Bahia MT; Martins-Filho OA; Dias JC; Albajar-Viñas P; Torres RM; Lana M
    Clin Vaccine Immunol; 2012 Aug; 19(8):1283-91. PubMed ID: 22739694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
    Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Chagas disease in the Bolivian population of Majorca (Spain).
    Favila Escobio P; Ribas J; G Morillo M; Rodríguez-Ramírez G; Vicens-Ferrer J; Esteva M
    Gac Sanit; 2015; 29(4):288-91. PubMed ID: 26026727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
    de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
    Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paediatric Chagas in a non-endemic area].
    Fumadó V; Juncosa T; Posada E; Fisa R; Gállego M; Gascón J
    Enferm Infecc Microbiol Clin; 2014 May; 32(5):293-6. PubMed ID: 24491481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany.
    Navarro M; Berens-Riha N; Hohnerlein S; Seiringer P; von Saldern C; Garcia S; Blasco-Hernández T; Navaza B; Shock J; Bretzel G; Hoelscher M; Löscher T; Albajar-Viñas P; Pritsch M
    BMJ Open; 2017 Jan; 7(1):e013960. PubMed ID: 28093440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia.
    Ramos JM; Ponce Y; Gallegos I; Flóres-Chávez M; Cañavate C; Gutiérrez F
    Pathog Glob Health; 2012 May; 106(2):102-6. PubMed ID: 22943545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens.
    Umezawa ES; Bastos SF; Coura JR; Levin MJ; Gonzalez A; Rangel-Aldao R; Zingales B; Luquetti AO; da Silveira JF
    Transfusion; 2003 Jan; 43(1):91-7. PubMed ID: 12519436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.
    Pinto AY; Valente Vda C; Coura JR; Valente SA; Junqueira AC; Santos LC; Ferreira AG; de Macedo RC
    PLoS One; 2013; 8(5):e64450. PubMed ID: 23724050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
    Furuchó CR; Umezawa ES; Almeida I; Freitas VL; Bezerra R; Nunes EV; Sanches MC; Guastini CM; Teixeira AR; Shikanai-Yasuda MA
    Trop Med Int Health; 2008 Dec; 13(12):1527-33. PubMed ID: 18983272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 - 2018.
    Guggenbühl Noller JM; Froeschl G; Eisermann P; Jochum J; Theuring S; Reiter-Owona I; Bissinger AL; Hoelscher M; Bakuli A; von Sonnenburg FF; Rothe C; Bretzel G; Albajar-Viñas P; Grout L; Pritsch M
    BMC Infect Dis; 2020 Dec; 20(1):919. PubMed ID: 33272201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.
    Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M
    J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the ARCHITECT Chagas
    Pérez-Ayala A; Fradejas I; Rebollo L; Lora-Pablos D; Lizasoain M; Herrero-Martínez JM
    Trop Med Int Health; 2018 Jun; 23(6):634-640. PubMed ID: 29683542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chagas disease in the Bolivian Chaco: Persistent transmission indicated by childhood seroscreening study.
    Hopkins T; Gonçalves R; Mamani J; Courtenay O; Bern C
    Int J Infect Dis; 2019 Sep; 86():175-177. PubMed ID: 31357060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.
    Yager JE; Lozano Beltran DF; Torrico F; Gilman RH; Bern C
    Glob Heart; 2015 Sep; 10(3):145-50. PubMed ID: 26407509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain.
    Roca C; Pinazo MJ; López-Chejade P; Bayó J; Posada E; López-Solana J; Gállego M; Portús M; Gascón J;
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1135. PubMed ID: 21572511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.